181 related articles for article (PubMed ID: 27839917)
21. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
[TBL] [Abstract][Full Text] [Related]
22. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
[TBL] [Abstract][Full Text] [Related]
23. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
[TBL] [Abstract][Full Text] [Related]
24. 3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents.
Das U; Lorand T; Dimmock SG; Perjesi P; Dimmock JR
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):259-63. PubMed ID: 24939095
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Cordeiro R; Kachroo M
Bioorg Med Chem Lett; 2020 Dec; 30(24):127655. PubMed ID: 33130292
[TBL] [Abstract][Full Text] [Related]
26. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
Reddy DS; Hosamani KM; Devarajegowda HC
Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
[TBL] [Abstract][Full Text] [Related]
28. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study.
Reddy DS; Kongot M; Netalkar SP; Kurjogi MM; Kumar R; Avecilla F; Kumar A
Eur J Med Chem; 2018 Apr; 150():864-875. PubMed ID: 29597169
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolone derivatives and their anti-tubercular activities.
Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS
Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Biological and Molecular Docking Studies of Thiazole-Thiadiazole derivatives as potential Anti-Tuberculosis Agents.
Shaikh SA; Labhade SR; Kale RR; Pachorkar PY; Meshram RJ; Jain KS; Labhade HS; Boraste DR; More RA; Chobe SS; Ballabh D; Wakchaure SN
Chem Biodivers; 2024 Jun; 21(6):e202400496. PubMed ID: 38700369
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
38. Discovery of in vitro antitubercular agents through in silico ligand-based approaches.
De Vita D; Pandolfi F; Cirilli R; Scipione L; Di Santo R; Friggeri L; Mori M; Fiorucci D; Maccari G; Arul Christopher RS; Zamperini C; Pau V; De Logu A; Tortorella S; Botta M
Eur J Med Chem; 2016 Oct; 121():169-180. PubMed ID: 27240272
[TBL] [Abstract][Full Text] [Related]
39. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
40. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]